In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Concentrix Corp (NASDAQ: CNXC) closed the day trading at $54.88 up 0.27% from the previous closing price of $54.73. In other words, the price has increased by $0.27 from its previous closing price. On the day, 0.75 million shares were traded.
Ratios:
For a better understanding of CNXC, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.37 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.27. For the most recent quarter (mrq), Quick Ratio is recorded 1.65 and its Current Ratio is at 1.65. In the meantime, Its Debt-to-Equity ratio is 1.42 whereas as Long-Term Debt/Eq ratio is at 1.36.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barrington Research on March 24, 2025, Reiterated its Outperform rating but revised its target price to $54 from $70 previously.
On October 03, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $70.
BofA Securities Upgraded its Underperform to Neutral on August 28, 2024, whereas the target price for the stock was revised from $65 to $85.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 30 ’25 when Twomey Cormac J sold 500 shares for $57.06 per share. The transaction valued at 28,530 led to the insider holds 38,130 shares of the business.
CORMAC TWOMEY bought 500 shares of CNXC for $28,530 on May 30 ’25. On Apr 30 ’25, another insider, Twomey Cormac J, who serves as the EVP, Global Ops & Delivery of the company, sold 500 shares for $50.70 each. As a result, the insider received 25,350 and left with 38,630 shares of the company.
Valuation Measures:
As of this moment, Concentrix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.74, and their Forward P/E ratio for the next fiscal year is 4.30. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.47. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.37 while its Price-to-Book (P/B) ratio in mrq is 0.87.
Stock Price History:
Over the past 52 weeks, CNXC has reached a high of $77.00, while it has fallen to a 52-week low of $36.28. The 50-Day Moving Average of the stock is 5.46%, while the 200-Day Moving Average is calculated to be 8.04%.
Shares Statistics:
A total of 63.81M shares are outstanding, with a floating share count of 45.26M. Insiders hold about 29.15% of the company’s shares, while institutions hold 79.82% stake in the company.
